Home Tags AbbVie

Tag: AbbVie

CytomX and AbbVie Jointly Develop and Commercialize Probody-drug Conjugates Directed...

Antibody-drug conjugates or ADCs combine the cytotoxic potential of chemotherapeutic drugs with the specificity of monoclonal antibodies.  One of the critical parameters effecting the efficacy,...

AbbVie Acquires Small API Site in Singapore

AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in...
FDA_EMA

Phase I Trial Results in GBM Lead to Orphan Drug Designation...

The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody drug conjugate, which is being evaluated for safety and efficacy in patients with glioblastoma multiform.